Nanobiotix (NBTX) News Today $20.97 -1.81 (-7.95%) Closing price 04:00 PM EasternExtended Trading$20.96 -0.01 (-0.03%) As of 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NBTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Nanobiotix (NASDAQ:NBTX) Shares Gap Down - Here's WhyOctober 7 at 11:53 AM | marketbeat.comHC Wainwright Increases Earnings Estimates for NanobiotixOctober 7 at 2:29 AM | americanbankingnews.comNanobiotix (NASDAQ:NBTX) Reaches New 12-Month High - Should You Buy?October 6 at 11:29 AM | marketbeat.comFY2027 EPS Estimates for Nanobiotix Boosted by HC WainwrightOctober 6 at 2:37 AM | marketbeat.comLeerink Partners Sticks to Its Buy Rating for Nanobiotix (NBTX)October 4 at 2:52 AM | theglobeandmail.comShort Interest in Nanobiotix S.A. Sponsored ADR (NASDAQ:NBTX) Decreases By 53.2%October 3, 2025 | marketbeat.comNanobiotix Reveals Promising Phase 1 Results for JNJ-1900 in Cancer TreatmentOctober 2, 2025 | theglobeandmail.comNanobiotix Shares Surge After Encouraging Esophageal Cancer Study ResultsOctober 2, 2025 | msn.comNanobiotix (NASDAQ:NBTX) Shares Gap Up - Still a Buy?October 2, 2025 | marketbeat.comNANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal CancerOctober 1, 2025 | globenewswire.comNanobiotix stock soars after promising cancer treatment resultsSeptember 30, 2025 | za.investing.comNanobiotix-J&J Therapy Shows Promise In Tough Head And Neck CancerSeptember 30, 2025 | uk.finance.yahoo.comNanobiotix Releases Half-Year Financial Report Highlighting JNJ-1900 DevelopmentsSeptember 30, 2025 | msn.comNanobiotix Reports Half-Year 2025 Financial Results and Strategic ProgressSeptember 30, 2025 | msn.comNANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial ResultsSeptember 30, 2025 | globenewswire.comNanobiotix (NASDAQ:NBTX) Reaches New 1-Year High - Here's WhySeptember 30, 2025 | marketbeat.comReviewing Lotus Pharmaceuticals (OTCMKTS:LTUS) & Nanobiotix (NASDAQ:NBTX)September 30, 2025 | americanbankingnews.comReviewing Nanobiotix (NASDAQ:NBTX) and Nuvilex (NASDAQ:PMCB)September 30, 2025 | americanbankingnews.comNANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCCSeptember 29, 2025 | globenewswire.comNanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading Volume - Should You Buy?September 29, 2025 | marketbeat.comNanobiotix (NASDAQ:NBTX) Shares Gap Up - Time to Buy?September 28, 2025 | americanbankingnews.comNanobiotix (NASDAQ:NBTX) Shares Gap Down - What's Next?September 25, 2025 | marketbeat.comNanobiotix (NASDAQ:NBTX) Hits New 52-Week High - Here's WhySeptember 23, 2025 | marketbeat.comNanobiotix (NASDAQ:NBTX) Trading 11.8% Higher - Time to Buy?September 22, 2025 | marketbeat.comNanobiotix price target raised to $14 from $9 at LeerinkSeptember 20, 2025 | msn.comNanobiotix (NASDAQ:NBTX) Sees Large Volume Increase - Here's What HappenedSeptember 20, 2025 | marketbeat.comNanobiotix (NBTX) Projected to Post Earnings on MondaySeptember 20, 2025 | marketbeat.comNanobiotix price target raised to EUR 13 from EUR 10 at H.C. WainwrightSeptember 19, 2025 | msn.comNanobiotix (NASDAQ:NBTX) Shares Gap Up - Should You Buy?September 19, 2025 | marketbeat.comShort Interest in Nanobiotix S.A. Sponsored ADR (NASDAQ:NBTX) Grows By 23.7%September 19, 2025 | marketbeat.comMelanoma Data Study Boosts J&J Partner Nanobiotix Stock On ThursdaySeptember 18, 2025 | benzinga.comNanobiotix: Today's Data Readout For Radiation Therapy Enhances Bull CaseSeptember 18, 2025 | seekingalpha.com4 Biotech Stocks at the Cutting Edge of Drug Delivery (MDCX, RNA, NBTX, ARWR)September 18, 2025 | theglobeandmail.comNanobiotix S.A. (NBTX) Discusses on New Phase 1 Results In Metastatic Melanoma ConferenceSeptember 18, 2025 | seekingalpha.comNanobiotix S.A. (NBTX) Discusses On New Phase 1 Results In Metastatic Melanoma Conference (Transcript)September 18, 2025 | seekingalpha.comNanobiotix (NASDAQ:NBTX) Reaches New 12-Month High - Here's WhySeptember 18, 2025 | marketbeat.comNanobiotix soars on positive phase 1 results for JNJ-1900 in melanomaSeptember 18, 2025 | msn.comNanobiotix announces new results from JNJ-1900 studySeptember 17, 2025 | msn.comNANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary ...September 17, 2025 | finance.yahoo.comNANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1September 17, 2025 | globenewswire.comNanobiotix (NASDAQ:NBTX) Shares Up 5.7% - What's Next?September 14, 2025 | marketbeat.comNanobiotix to Present at H.C. Wainwright Investment ConferenceSeptember 5, 2025 | theglobeandmail.comNanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 2, 2025 | globenewswire.comNanobiotix (NASDAQ:NBTX) Stock Price Down 5.2% - Here's WhyAugust 23, 2025 | marketbeat.comShort Interest in Nanobiotix S.A. Sponsored ADR (NASDAQ:NBTX) Increases By 209.8%August 18, 2025 | marketbeat.comNanobiotix (NASDAQ:NBTX) Stock Price Up 2.9% - Should You Buy?July 30, 2025 | marketbeat.comGuggenheim Reaffirms Their Buy Rating on Nanobiotix (NBTX)July 25, 2025 | theglobeandmail.comNANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3) - MorningstarJuly 8, 2025 | morningstar.comMNanobiotix (NASDAQ:NBTX) Stock Price Down 2.5% - Should You Sell?July 8, 2025 | marketbeat.comNANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3)July 7, 2025 | globenewswire.com Get Nanobiotix News Delivered to You Automatically Sign up to receive the latest news and ratings for NBTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NBTX Media Mentions By Week NBTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBTX News Sentiment▼0.450.55▲Average Medical News Sentiment NBTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBTX Articles This Week▼182▲NBTX Articles Average Week Get the Latest News and Ratings for NBTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Nanobiotix and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AMNEAL PHARMACEUTICALS News Today uniQure News Today Xenon Pharmaceuticals News Today Viking Therapeutics News Today CG Oncology News Today MorphoSys News Today Immunovant News Today Apellis Pharmaceuticals News Today Ultragenyx Pharmaceutical News Today HUTCHMED News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NBTX) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanobiotix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
